Clinical trial screening questions for seniors and families in Los Angeles. Educational navigation only; study details must be confirmed by the research team.
Potential Compensation
Study Duration
Study Location
Age-related macular degeneration research may study vision monitoring, retinal imaging, injections, supplements, investigational treatments, or ways to protect central vision and daily function for older adults.
All Seniors Foundation can help you ask about current screening and prepare practical questions before speaking with a research team. A screening inquiry does not guarantee enrollment, treatment, payment, or medical benefit. Final eligibility, study availability, visit requirements, risks, possible benefits, and any compensation must be confirmed by the study team during formal screening and informed consent.
A coordinator may ask about AMD diagnosis, wet or dry AMD, vision changes, prior injections, eye imaging, eye surgeries, medications, diabetes, smoking history, and ability to attend eye visits. Some studies may include dilated eye exams, retinal imaging, vision testing, medication review, or follow-up calls.
The research team should explain the study purpose, what is optional or required, how personal information is protected, whether your regular clinician should be involved, and what choices you have before signing any consent document.
Before you call, write down which eye is affected, whether AMD is wet or dry, when your last eye exam occurred, whether injections were given, and whether straight lines look wavy or central vision is blurry. Keep your ophthalmologist name and any recent eye records nearby if available.
Helpful preparation makes the first conversation more productive. You can also write down transportation needs, caregiver availability, preferred call times, language needs, and any questions your family or clinician wants answered before you continue.
After a screening call, ask whether the study changes current eye treatment, whether injections or imaging are required, who handles urgent vision changes, and whether your regular eye doctor receives study information.
If the study is not a fit, ask whether there are other research options, educational resources, or follow-up questions you should discuss with your personal healthcare provider.
We can help you organize questions, prepare a medication list, identify records that may be useful, and understand what to ask before deciding whether a study is right for you. We encourage seniors and families to involve the senior’s primary doctor or specialist before making decisions about research participation.
For general research education, review the ClinicalTrials.gov guide to clinical studies and NIH Clinical Research Trials and You. For condition background, review National Eye Institute information about AMD.
Call All Seniors Foundation or submit the screening inquiry form to ask whether age-related macular degeneration research screening is currently available. You can ask questions first and decide later whether to continue with formal screening.
A screening call helps you understand the study, possible time commitment, informed consent process, and whether the research team may be a fit for your situation.
Some studies may provide compensation for completed study visits, travel, or time, depending on the protocol and eligibility.
Study-related visits are reviewed by trained research staff, with screening steps designed to protect participant safety.
Volunteers help researchers answer important health questions that may improve care options in the future.
A coordinator can explain what is required before you decide whether to continue with formal screening.
You can ask questions about visits, risks, possible benefits, privacy, and what participation would involve.
Participation is voluntary, and the research team should explain consent, withdrawal, and next steps before enrollment.
These points are only a starting guide. Final eligibility, availability, and enrollment decisions are confirmed by the study team.
Study openings, screening windows, and eligibility requirements can change.
No-obligation inquiry. Participation is voluntary and depends on formal screening.
Get answers to common questions before deciding whether to ask about formal screening
No. A screening inquiry is only the first step. The study team confirms eligibility, availability, requirements, risks, possible benefits, and any compensation before enrollment.
The team may ask about age-related macular degeneration, current symptoms, medications, medical history, recent test results, and whether study visits or follow-up tasks are realistic.
Depending on the protocol, screening may include vision testing, dilated eye exam, retinal imaging, medication review, or eye-history questionnaires. The research team should explain each step before you decide whether to continue.
Not necessarily. Some studies include randomization, placebo controls, monitoring only, or comparison groups. The informed consent process should explain how assignment works.
Yes. Research participation is voluntary. Consent materials should explain how withdrawal works and who to contact with questions or concerns.
Clinical research should be reviewed, explained clearly, and built around informed consent, privacy, and participant choice.
Drug and device studies may follow applicable FDA and research oversight requirements.
Institutional review boards help evaluate participant protections and informed consent materials.
The study team should explain how personal and health information is collected, used, and protected.
You can ask questions, review consent materials, and decide whether participation is right for you.
Contact All Seniors Foundation to ask whether screening is available and what questions to prepare before speaking with the study team.
(818) 581-4101
Available 8 AM - 6 PM, Mon-Sun
16101 Ventura Blvd Suite 300
Encino, CA 91436
Only your name, phone number, and consent are required. Email and other details are optional.
Clinical trial education for older adults
This page is an educational starting point for understanding Macular Degeneration Clinical Trial Screening. Trial availability, eligibility, risks, benefits, costs, and participation requirements must be confirmed with the responsible study team and licensed healthcare professionals.
It introduces practical questions older adults and families may want to discuss with a study team, including eligibility, possible risks and benefits, visit requirements, transportation, costs, and follow-up.
No. It does not promise enrollment or medical benefit. The responsible study team must confirm whether a study is active and whether a person may qualify.
Write down current diagnoses, medications, recent test results, mobility or transportation needs, and questions for the study team. Discuss participation with licensed healthcare professionals before making a decision.
Website content is informational and is not medical, legal, financial, or emergency advice. For emergencies, call 911 or go to the nearest emergency room.
